patient tracking News
-
The future of precise personalised robotic physiotherapy
Imagine a robot that gives therapeutic massages. The essence of this new medical advance is to improve access to physical therapy for people with chronic back pain. The EU-funded ADAMO Robot project is developing a robotic arm that provides precise therapeutic treatment by applying compressed air to a patient’s back. An artificial intelligence (AI) system can monitor the progress of the ...
By Adamo Robot
-
Innovative IAP Event
Recently The Indian Association of Physiotherapists (IAP) had conducted their 59th conference in Kolkata from 7th - 8th May 2022 and what a successful event it was for the physiotherapist's community which enables them to display their innovative potential and creative abilities to bring a revolution in the field of physiotherapy. IAP is a non-profit, non-governmental organization that ...
-
Modernizing the Patient Experience
There are self-driving cars, 5G smartphones, and now planes that travel from New York to London in 3.5 hours. The world we live in and the technology we use are rapidly evolving. But, when it comes to drug delivery methods, the 160-year old technology behind the needle and syringe has yet to catch wind of any radical transformation. With cutting-edge technology from MIT, Portal Instruments aims ...
-
Showcase
New device offers a mouthful of data for chronic diseases
Aidar Health, formerly known as Multisensor Diagnostics, has developed a portable hand-held device that allows patients to measure and track vital signs in a matter of seconds. Roughly the size of an iPhone, MouthLab consists of a hand unit and a mouthpiece that fits between the teeth and lips. The mouthpiece uses special sensors to gather information from breathing patterns, saliva and blood ...
By Aidar Health
-
Flow Sciences, Inc. Supplies 10 Enclosures for High Capacity COVID-19 Testing
Flow Sciences, Inc., a leading global provider of containment solutions, recently worked with Sema4, a patient-centered health intelligence company, to provide enclosures designed to protect its laboratory personnel while processing patient samples for COVID-19. Due to the crucial nature of Sema4’s work, Flow Sciences designed, engineered, tested, and delivered all ten enclosures to ...
-
ABLE Care – the rehabilitation app
1. What is ABLE Care? (what devices does it work on) ABLE Care is a software application for smartphones that allows clinicians to control, adjust parameters and monitor ABLE Exoskeleton gait metrics in real-time during rehabilitation sessions. In addition, ABLE Care serves as an intermediate platform to save the data collected during rehabilitation in the cloud storage system and allows ...
-
MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b
MODAG, a German biotechnology company focused on the development of disease-modifying small molecule therapeutics for neurodegenerative diseases, today announced the clinical trial initiation of, and recruitment for, a first-in-human Phase 1 study of lead candidate, anle138b in healthy volunteers. The compound is initially being developed for the treatment of Multiple System Atrophy (MSA), with ...
By MODAG GmbH
-
Meissa Vaccines Receives U.S. FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine
SOUTH SAN FRANCISCO, Calif, January 10, 2020 – Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to MV-012-968, an investigational, live attenuated vaccine for protection against respiratory syncytial virus (RSV) ...
-
SAGA expands research collaboration with University College London Cancer Institute
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announced an expanded research collaboration with Professor Charles Swanton, at the University College London (UCL) Cancer Institute. Last year, SAGA and UCL entered into a research collaboration on a limited number of ...
-
ITM Receives FDA Fast Track Designation for Radionuclide Therapy Candidate ITM-11 (n.c.a. 177Lu-edotreotide) in Neuroendocrine Tumors (GEP-NETs)
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track designation for ITM-11 (n.c.a. 177Lu-edotreotide), an investigational radiopharmaceutical for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). ITM-11 is being evaluated as a Targeted ...
-
Selux Diagnostics Announces Additional $50 Million in Series C Funding
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced it has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform. "This Series C funding allows us to build out our ...
-
VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders
VeriSIM Life (VeriSIM), the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced that it has entered into a partnership agreement with Total Brain, an applied, integrative neuroscience company, to create breakthrough neurodata-driven actionable insights for developing novel drugs to treat a wide range of neurological ...
By VeriSIM Life
-
Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference
Beacon Biosignals, a startup that applies AI to EEG to unlock precision medicine for neurological and psychiatric disorders, presented research at the Alzheimer's Association International Conference, which took place July 31–Aug. 4, 2022, in San Diego. Medical Director Jay Pathmanathan, MD, PhD, discussed how the company has applied its machine learning platform to standard ...
-
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation (TAVI) System has been used on an additional four patients in the ongoing international, single-arm, open-label early feasibility study (EFS). Initial post-implantation results from these patients, who received a 24mm valve, show favorable low aortic ...
-
Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz Immunotherapy Platform
Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that the Company has signed an agreement with Greenstone Biosciences Inc. in Palo Alto, CA for the development of a human induced ...
-
Immatics Announces Second Quarter 2021 Financial Results and Provides Business Update
Immatics N.V. (NASDAQ: IMTX; “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, today reported its financial results for the quarter ended June 30, 2021 and provided a business update on its progress over the reporting period. “An important development during the second quarter of 2021 ...
-
PeriGen Deploys Mobile Version of PeriWatch Vigilance to Further Protect Moms and Babies During Childbirth
PeriGen Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today introduced PeriWatch Vigilance® Mobile, a full-function browser-based solution providing access to its early warning system (EWS) and clinical decision support tool. By providing remote access to the full range of conditions monitored by PeriWatch Vigilance, the new solution ...
-
Coala introduces more advancements for the heart
Introducing the new Coala Monitoring Report – enhanced to provide physicians with a comprehensive summary of Coala generated data. The report is customizable and can be created on-demand at any time. An ideal tool to effectively track ECG and patient-reported symptoms, to support diagnosis, and document 30-day Event or long-term RPM billing. Coala is the ideal solution for long-term, ...
-
SCL Health to Deploy System-Wide OB Hub Powered by PeriWatch Command Center
PeriGen Inc., the market leader in applying artificial intelligence (AI) to improve safety in childbirth, today announced that SCL Health, a health system operating eight hospitals and 150 clinics in Colorado and Montana, is launching a centralized SCL Health OB Hub utilizing PeriGen’s PeriWatch Command Center enterprise-wide telehealth-platform. Through the OB Hub, a dedicated team of ...
-
GERDHelp Mobile App to Assist GERD Patients in Navigating Their Journey With Individualized Education and Support, Provided by EndoGastric Solutions®
REDMOND, Wash – June 23, 2021 – EndoGastric Solutions® today released the GERDHelp™ mobile application that will virtually guide gastroesophageal reflux disease (GERD) sufferers through an individualized treatment pathway providing education and customized support along the patient journey. Patients can easily record GERD-related symptoms, as well as their frequency, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you